Current reports

Up-to-date announcements resulting from information obligations of listed companies.

Current reports published before January 1, 2024 are available on the Polish section:

Report Details Publication Action
2024 ESPI Report 29/2024

Information on the conclusion of a significant sales agreement

03.06.2024 Read more
2024 ESPI Report 28/2024

Information on the conclusion of a significant agreement

24.05.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 27/2024

Partnership agreement for exclusive distribution of Symani microsurgery robots

22.05.2024 other-issues Read more
2024 ESPI Report 26/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

17.05.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 25/2024

Information on the conclusion of a significant agreement

06.05.2024 sale-agreements Read more
2024 ESPI Report 24/2024

Contract for the exclusive distribution of Qure.ai’s global artificial intelligence solution to assess the results of radiology tests in Poland, the Czech Republic and Slovakia

19.04.2024 other-issues Read more
2024 ESPI Report 23/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

18.04.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 22/2024

Operational highlights of the medical devices, IT solutions and services sales segment

10.04.2024 other-issues Read more
2024 ESPI Report 21/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

09.04.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 20/2024

Information on the conclusion of a significant sales agreement

28.03.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 19/2024

Notification of transactions executed by a person discharging managerial responsibilities

12.03.2024 other-issues Read more
2024 ESPI Report 18/2024

Information on the conclusion of a significant sales agreement

08.03.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 17/2024

List of shareholders holding at least 5% of the total number of votes at the Ordinary Shareholder Meeting on 26 February 2024

27.02.2024 shareholder-meetings Read more
2024 ESPI Report 16/2024

Resolutions adopted by the Ordinary Shareholder Meeting of Synektik SA on 26 February 2024

27.02.2024 shareholder-meetings Read more
2024 ESPI Report 15/2024

Dividend payout resolution

26.02.2024 dividend,shareholder-meetings Read more
2024 ESPI Report 14/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

26.02.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 13/2024

Notification of transactions executed by a person discharging managerial responsibilities

23.02.2024 other-issues Read more
2024 ESPI Report 12/2024

Information on the conclusion of a significant sales agreement

22.02.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 11/2024

Expansion of a cooperation agreement

22.02.2024 other-issues Read more
2024 ESPI Report 10/2024

Notification of transactions executed by a person discharging managerial responsibilities

21.02.2024 other-issues Read more
2024 ESPI Report 9/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

19.02.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 8/2024

Estimated revenue in Q1 2023

31.01.2024 other-issues Read more
2024 ESPI Report 7/2024

Obtaining a patent for a cardiac marker in Japan

25.01.2024 cardiotracer Read more
2024 Appendix 2 – ESPI Report 6/2024

Auditor's assessment of Synektik's report on payments of the Management Board and Supervisory Board for FY2022

25.01.2024 shareholder-meetings Read more
2024 Appendix 1 – ESPI Report 6/2024

Report on payments of the Management Board and Supervisory Board for FY2022

25.01.2024 shareholder-meetings Read more
2024 ESPI Report 6/2024

Completion of documentation to be discussed at the Ordinary General Meeting of SYNEKTIK SA

25.01.2024 shareholder-meetings Read more
2024 Appendix – ESPI Report 5/2024/K

Corrected draft resolutions attached to ESPI report 5/2024/K

22.01.2024 shareholder-meetings Read more
2024 ESPI Report 5/2024/K

Correction of current report ESPI 5/2024 - Announcement on convening the Ordinary General Meeting of Shareholders for February 26, 2024


22.01.2024 shareholder-meetings Read more
2024 Appendixes – ESPI Report 5/2024 22.01.2024 shareholder-meetings Read more
2024 ESPI Report 5/2024

Announcement on the convening of the Ordinary General Meeting of Shareholders for February 26, 2024

22.01.2024 shareholder-meetings Read more
2024 ESPI Report 4/2024

Recommendation of the Management Board on the payment of dividends for FY2022

19.01.2024 dividend Read more
2024 ESPI Report 3/2024

Establishment of a bank guarantee for a counterparty

17.01.2024 other-issues Read more
2024 ESPI Report 2/2024

Update on the cardiotracer project

10.01.2024 cardiotracer Read more
2024 ESPI Report 1/2024

Selected operating data of the medical devices, IT solutions and services sales segment

08.01.2024 other-issues Read more